CGRP vs CART Peptide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by alternative splicing of the calcitonin gene in neurons. It is the most abundant neuropeptide in the sensory nervous system, expressed in trigeminal ganglion neurons and released from perivascular n...
Calculate CGRP dose →CART (Cocaine- and Amphetamine-Regulated Transcript) peptide is a neuropeptide encoded by the CARTPT gene, named because its mRNA is dramatically upregulated in the striatum by cocaine and amphetamine administration. CART peptide is produced in the arcuate nucleus, nucleus accumb...
Calculate CART Peptide dose →| Parameter | CGRP | CART Peptide |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | FDA Approved (Anti-CGRP antibodies) | Research |
| Half-Life | ~7-10 min (plasma; native) | Unknown |
| Typical Dose | Anti-CGRP mAbs: 70-240 mg SC monthly or quarterly | 0.1-10 nmol (ICV, animal) |
| Frequency | Monthly or quarterly (approved antibodies) | Variable |
| Route | Endogenous; IV/SC (research) | Intracerebroventricular (animal research) |
| FDA Status | Anti-CGRP antibodies approved (erenumab, fremanezumab, galcanezumab, eptinezumab) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.